T1	PROC 47 68	Estudio multicéntrico
#1	AnnotatorNotes T1	C1096776; Multicenter Study; Research Activity
T2	DISO 232 270	infección vaginal bacteriana o fúngica
T3	PROC 852 876	consentimiento informado
#2	AnnotatorNotes T3	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T4	CHEM 121 133	ácido bórico
#3	AnnotatorNotes T4	C0006020; boric acid; Inorganic Chemical · Pharmacologic Substance
T5	CHEM 160 167	fármaco
#4	AnnotatorNotes T5	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T6	PROC 74 94	comparar la eficacia
#5	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
T7	PROC 294 322	Estudio piloto multicéntrico
T8	PROC 328 348	comparar la eficacia
#6	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
T9	Route 361 370	vaginales
T10	CHEM 375 387	ácido bórico
#7	AnnotatorNotes T10	C0006020; boric acid; Inorganic Chemical · Pharmacologic Substance
T11	CHEM 428 435	fármaco
#8	AnnotatorNotes T11	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T12	DISO 500 553	vulvovaginitis de etiología bacteriana o candidiásica
T13	DISO 578 622	Infecciones vaginales por hongos o bacterias
T14	DISO 649 689	Vulvovaginitis bacteriana o candidiásica
T15	DISO 755 779	manifestaciones clínicas
#9	AnnotatorNotes T15	C0037088; Signs and Symptoms; Sign or Symptom
T16	DISO 783 796	VV infecciosa
#10	AnnotatorNotes T16	C0856854; Vulvovaginitis infection; Disease or Syndrome
T17	DISO 993 1007	Herpes simplex
#11	AnnotatorNotes T17	C0019348; Herpes Simplex Infections; Disease or Syndrome
T18	CHEM 1018 1031	antimicóticos
#12	AnnotatorNotes T18	C0003308; Antifungal Agents; Pharmacologic Substance
T19	PROC 1140 1167	tratamiento con probióticos
#13	AnnotatorNotes T19	C2242626; Probiotic therapy; Therapeutic or Preventive Procedure
T20	CHEM 1169 1190	complejos vitamínicos
#14	AnnotatorNotes T20	C0042890; Vitamins; Organic Chemical · Pharmacologic Substance · Vitamin
T21	PROC 1243 1255	evaluaciones
#15	AnnotatorNotes T21	C1261322; Evaluation procedure; Health Care Activity
T22	DISO 1460 1476	inmunodeprimidas
#16	AnnotatorNotes T22	C0085393; Immunocompromised Host; Finding
T23	PROC 1561 1572	seguimiento
#17	AnnotatorNotes T23	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T24	ANAT 242 249	vaginal
#18	AnnotatorNotes T24	C0042232; Vagina; Body Part, Organ, or Organ Component | C1278985; Entire vagina; Body Part, Organ, or Organ Component
T25	ANAT 590 599	vaginales
#19	AnnotatorNotes T25	C0042232; Vagina; Body Part, Organ, or Organ Component | C1278985; Entire vagina; Body Part, Organ, or Organ Component
T26	Date 13 17	2016
T27	Form 98 106	cápsulas
#20	AnnotatorNotes T27	C4722245; Capsule Dose Form Category; Functional Concept
T28	LIVB 136 147	probióticos
#21	AnnotatorNotes T28	C0525033; Probiotics; Bacterium
T29	LIVB 218 227	pacientes
#22	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	LIVB 250 260	bacteriana
#23	AnnotatorNotes T30	C0004611; Bacteria; Bacterium
T31	LIVB 263 270	fúngica
#24	AnnotatorNotes T31	C0016832; Fungi; Fungus
T32	Form 352 360	cápsulas
#25	AnnotatorNotes T32	C4722245; Capsule Dose Form Category; Functional Concept
T33	LIVB 486 495	pacientes
#26	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 528 538	bacteriana
#27	AnnotatorNotes T34	C0004611; Bacteria; Bacterium
T35	LIVB 613 622	bacterias
#28	AnnotatorNotes T35	C0004611; Bacteria; Bacterium
T36	LIVB 664 674	bacteriana
#29	AnnotatorNotes T36	C0004611; Bacteria; Bacterium
T37	LIVB 716 723	Mujeres
#30	AnnotatorNotes T37	C0043210; Woman; Population Group
T38	Age 732 740	≥18 años
T39	LIVB 743 750	Mujeres
#31	AnnotatorNotes T39	C0043210; Woman; Population Group
T40	LIVB 799 806	Mujeres
#32	AnnotatorNotes T40	C0043210; Woman; Population Group
T41	LIVB 924 945	Chlamydia trachomatis
#33	AnnotatorNotes T41	C0008151; Chlamydia trachomatis; Bacterium
T42	LIVB 969 990	Neisseria gonorrhoeae
#34	AnnotatorNotes T42	C0027573; Neisseria gonorrhoeae; Bacterium
T43	LIVB 1034 1045	probióticos
#35	AnnotatorNotes T43	C0525033; Probiotics; Bacterium
T44	Duration 1054 1075	las 2 últimas semanas
T45	LIVB 1098 1107	Pacientes
#36	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 1156 1167	probióticos
#37	AnnotatorNotes T46	C0525033; Probiotics; Bacterium
T48	LIVB 1271 1292	Pacientes embarazadas
#38	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group + C0033011; Pregnant Women; Population Group
T49	LIVB 1296 1305	Pacientes
#39	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Spec_cue 1306 1321	susceptibles de
T51	LIVB 1346 1355	Pacientes
#40	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 1413 1446	Pacientes en periodo de lactancia
#41	AnnotatorNotes T52	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T53	LIVB 1450 1459	Pacientes
#42	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 1480 1489	Pacientes
#43	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 1519 1531	investigador
#44	AnnotatorNotes T55	C0035173; Research Personnel; Professional or Occupational Group
T57	LIVB 604 610	hongos
#45	AnnotatorNotes T57	C0016832; Fungi; Fungus
T58	LIVB 993 999	Herpes
T59	PHYS 1281 1292	embarazadas
#46	AnnotatorNotes T59	C0032961; Pregnancy; Organism Function
T60	PHYS 1331 1342	embarazadas
#47	AnnotatorNotes T60	C0032961; Pregnancy; Organism Function
T61	Route 107 116	vaginales
T62	LIVB 390 400	L. gasseri
#48	AnnotatorNotes T62	C0317620; Lactobacillus gasseri; Bacterium
T63	LIVB 403 415	L. rhamnosus
#49	AnnotatorNotes T63	C0317597; Lactobacillus casei rhamnosus; Bacterium
T64	LIVB 541 553	candidiásica
#50	AnnotatorNotes T64	C0006836; Candida; Fungus
T65	LIVB 677 689	candidiásica
#51	AnnotatorNotes T65	C0006836; Candida; Fungus
T66	LIVB 947 967	Trichomona vaginalis
#52	AnnotatorNotes T66	C0040922; Trichomonas vaginalis; Eukaryote
T47	PHYS 1370 1382	menstruación
#53	AnnotatorNotes T47	C0025344; Menstruation; Organism Function
T67	PHYS 1437 1446	lactancia
#54	AnnotatorNotes T67	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
A1	Assertion T60 Speculated
#55	AnnotatorNotes T61	C1522570; Vaginal Route of Drug Administration; Functional Concept 
#56	AnnotatorNotes T9	C1522570; Vaginal Route of Drug Administration; Functional Concept 
#57	AnnotatorNotes T7	C1096776; Multicenter Study; Research Activity + C0031928; Pilot Projects; Research Activity
#58	AnnotatorNotes T58	C0019369; Herpesviridae; Virus
T56	Neg_cue 1543 1545	no
T68	Observation 1546 1572	completarán el seguimiento
A2	Assertion T68 Negated
#59	AnnotatorNotes T68	C5554829; Follow-Up Completed; Finding (?)
R1	Has_Drug_Form Arg1:T4 Arg2:T27	
R2	Has_Route_or_Mode Arg1:T4 Arg2:T61	
R3	Combined_with Arg1:T4 Arg2:T28	
R4	Has_Route_or_Mode Arg1:T5 Arg2:T61	
R5	Experiences Arg1:T29 Arg2:T4	
R6	Experiences Arg1:T29 Arg2:T5	
R7	Has_Drug_Form Arg1:T5 Arg2:T27	
R8	Location_of Arg1:T24 Arg2:T2	
R9	Experiences Arg1:T29 Arg2:T2	
R10	Causes Arg1:T30 Arg2:T2	
R11	Causes Arg1:T31 Arg2:T2	
R12	Has_Drug_Form Arg1:T10 Arg2:T32	
R13	Has_Route_or_Mode Arg1:T10 Arg2:T9	
R14	Combined_with Arg1:T10 Arg2:T62	
R15	Combined_with Arg1:T62 Arg2:T63	
R16	Has_Drug_Form Arg1:T11 Arg2:T32	
R17	Has_Route_or_Mode Arg1:T11 Arg2:T9	
R18	Experiences Arg1:T33 Arg2:T10	
R19	Experiences Arg1:T33 Arg2:T11	
R20	Experiences Arg1:T33 Arg2:T12	
R21	Causes Arg1:T34 Arg2:T12	
R22	Causes Arg1:T64 Arg2:T12	
R23	Causes Arg1:T57 Arg2:T13	
R24	Causes Arg1:T35 Arg2:T13	
R25	Location_of Arg1:T25 Arg2:T13	
R26	Causes Arg1:T36 Arg2:T14	
R27	Causes Arg1:T65 Arg2:T14	
R28	Has_Age Arg1:T37 Arg2:T38	
R29	Experiences Arg1:T39 Arg2:T15	
R30	Causes Arg1:T16 Arg2:T15	
R31	Experiences Arg1:T39 Arg2:T16	
T69	Observation 811 829	acepten participar
R33	Overlap Arg1:T69 Arg2:T3	
R34	Causes Arg1:T58 Arg2:T17	
T70	Observation 906 920	Cuadro clínico
R35	Causes Arg1:T41 Arg2:T70	
R36	Causes Arg1:T66 Arg2:T70	
R37	Causes Arg1:T42 Arg2:T70	
R38	Causes Arg1:T17 Arg2:T70	
R39	Has_Duration_or_Interval Arg1:T43 Arg2:T44	
R40	Has_Duration_or_Interval Arg1:T18 Arg2:T44	
T71	PROC 1087 1094	estudio
#61	AnnotatorNotes T71	C0008976; Clinical Trials; Research Activity
R41	Before Arg1:T18 Arg2:T71	
R42	Before Arg1:T43 Arg2:T71	
R43	Experiences Arg1:T45 Arg2:T19	
R44	Experiences Arg1:T45 Arg2:T20	
R45	Experiences Arg1:T45 Arg2:T21	
T72	CONC 1201 1211	interferir
A3	Assertion T72 Speculated
#62	AnnotatorNotes T72	C0521102; Interferes with; Functional Concept
R46	Used_for Arg1:T46 Arg2:T19	
R49	Experiences Arg1:T48 Arg2:T59	
R50	Experiences Arg1:T49 Arg2:T60	
R51	Speculation Arg1:T50 Arg2:T60	
R52	Experiences Arg1:T51 Arg2:T47	
T73	CONC 1400 1409	inclusión
#63	AnnotatorNotes T73	C1512693; Inclusion; Qualitative Concept
R53	Overlap Arg1:T47 Arg2:T73	
R54	Experiences Arg1:T52 Arg2:T67	
R55	Experiences Arg1:T53 Arg2:T22	
R57	Negation Arg1:T56 Arg2:T68	
#60	AnnotatorNotes T69	C1302239; Patient consented to clinical trial; Finding
#64	AnnotatorNotes T2	C0860029; Vaginal Yeast Infections; Disease or Syndrome (?) | C4324706; Bacterial vulvovaginitis; Disease or Syndrome
#65	AnnotatorNotes T12	C0860029; Vaginal Yeast Infections; Disease or Syndrome (?) | C4324706; Bacterial vulvovaginitis; Disease or Syndrome
#66	AnnotatorNotes T13	C0860029; Vaginal Yeast Infections; Disease or Syndrome (?) | C4324706; Bacterial vulvovaginitis; Disease or Syndrome
#67	AnnotatorNotes T14	C0860029; Vaginal Yeast Infections; Disease or Syndrome (?) | C4324706; Bacterial vulvovaginitis; Disease or Syndrome
A4	Experiencer T29 Patient
A5	Experiencer T33 Patient
A6	Experiencer T37 Patient
A7	Experiencer T39 Patient
A8	Experiencer T40 Patient
A9	Experiencer T45 Patient
A10	Experiencer T48 Patient
A11	Experiencer T49 Patient
A12	Experiencer T51 Patient
A13	Experiencer T52 Patient
A14	Experiencer T53 Patient
A15	Experiencer T54 Patient
A16	Experiencer T55 Other
A17	Status T68 Future
